Bio Accounts Payable from 2010 to 2025

Stocks . Australia . 
Stock . Bio Gene Technology
BGT Stock   0.03  0  2.94%   
Bio Gene Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable will likely drop to about 40.4 K in 2025. Accounts Payable is the amount Bio Gene Technology owes to suppliers or vendors for products or services received but not yet paid for. It represents Bio Gene's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2017-03-31
Previous Quarter
454.9 K
Current Value
47.2 K
Quarterly Volatility
213.6 K
 
Covid
Check Bio Gene financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Gene's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.4 K, Interest Expense of 63.8 K or Selling General Administrative of 1.7 M, as well as many indicators such as . Bio financial statements analysis is a perfect complement when working with Bio Gene Valuation or Volatility modules.
  
This module can also supplement various Bio Gene Technical models . Check out the analysis of Bio Gene Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bio Stock Analysis

When running Bio Gene's price analysis, check to measure Bio Gene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Gene is operating at the current time. Most of Bio Gene's value examination focuses on studying past and present price action to predict the probability of Bio Gene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Gene's price. Additionally, you may evaluate how the addition of Bio Gene to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY